A novel lipotherapy to reduce infarct size following myocardial infarction
Ended Project Grant Awarded Last action
- Award ID
- R44HL132649
- Recipient
-
Endoprotech Inc. UEI TGWXNHCYTTR3
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,485,754
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Place of performance
- Kentucky, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $736,042 | |
| Original award | $749,712 |
Quick answers
Who received award R44HL132649?
R44HL132649 was awarded to Endoprotech Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on July 1, 2016.
How much is award R44HL132649 worth?
$1,485,754 has been obligated on R44HL132649.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award